Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related ADXS
56 Biggest Movers From Yesterday
Mid-Afternoon Market Update: Crude Oil Up Over 1.5%; Whiting Petroleum Shares Climb After Strong Q4 Results
Midday Gainers / Losers (2/22/2018) (Seeking Alpha)
Related AVY
Benzinga's Top Upgrades, Downgrades For February 12, 2018
Benzinga's Top Upgrades, Downgrades For February 1, 2018

Analysts at Janney Capital initiated coverage on Advaxis, Inc. (NASDAQ: ADXS) with a Buy rating. The target price for Advaxis is set to $26. Advaxis shares closed at $18.97 yesterday.

Analysts at KeyBanc initiated coverage on Avery Dennison Corp (NYSE: AVY) with a Sector Weight rating. Avery Dennison's shares closed at $60.51 yesterday.

Analysts at Goldman Sachs initiated coverage on Assurant, Inc. (NYSE: AIZ) with a Buy rating. The target price for Assurant is set to $72. Assurant's shares closed at $64.92 yesterday.

Needham initiated coverage on ON Semiconductor Corp (NASDAQ: ON) with a Buy rating. The target price for ON Semiconductor is set to $17. ON Semiconductor shares closed at $12.44 yesterday.

Analysts at JP Morgan initiated coverage on Adobe Systems Incorporated (NASDAQ: ADBE) with a Overweight rating. The target price for Adobe Systems is set to $91. Adobe Systems' shares closed at $79.43 yesterday.

Stephens & Co. initiates coverage on Good Times Restaurants Inc. (NASDAQ: GTIM) with a Overweight rating. The target price for Good Times Restaurants is set to $11.50. Good Times Restaurants' shares closed at $9.05 yesterday.

Analysts at Oppenheimer initiated coverage on Trillium Therapeutics Inc. (NASDAQ: TRIL) with a Outperform rating. The target price for Trillium Therapeutics is set to $32. Trillium Therapeutics' shares closed at $18.57 yesterday.

Leerink Swann initiated coverage on Paratek Pharmaceuticals Inc (NASDAQ: PRTK) with a Outperform rating. The target price for Paratek Pharmaceuticals is set to $43. Paratek Pharmaceuticals' shares closed at $27.80 yesterday.

Latest Ratings for ADXS

DateFirmActionFromTo
Aug 2016BarclaysMaintainsOverweight
Feb 2016BarclaysMaintainsOverweight
Dec 2015Janney CapitalAssumesBuy

View More Analyst Ratings for ADXS
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ADBE + ADXS)

View Comments and Join the Discussion!